From Nasdaq: 2025-02-18 09:48:00

Zacks.com Analyst Blog highlights Apple Inc., Eli Lilly and Co., Shopify Inc., and ImmuCell Corp. as top research reports. Apple’s revenue growth expected in Q2 2025, driven by Services segment. Eli Lilly’s new drugs contribute to growth, but concerns about moderating demand. Shopify’s merchant base expansion boosts growth. ImmuCell sees sales growth driven by market-leading product. ATM offerings support growth initiatives, but regulatory delays and competition pose risks.



Read more at Nasdaq: The Zacks Analyst Blog Highlights Apple, Eli Lilly, Shopify and ImmuCell